Pharmaceutical preparations for the treatment of genetic disorders; Pharmaceutical preparations for the treatment of Angelman Syndrome; Gene therapy products for the treatment of genetic disorders, namely, genetically engineered genes for the production of proteins; Gene therapy products for the treatment of Angelman Syndrome, namely, genetically engineered genes for the production of proteins